Brian C. Stephenson - 05 Jan 2023 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Secretary, Treasurer & CFO
Signature
/s/ Brian C. Stephenson
Issuer symbol
BBIO
Transactions as of
05 Jan 2023
Net transactions value
-$468,470
Form type
4
Filing time
06 Jan 2023, 19:38:34 UTC
Previous filing
18 Nov 2022
Next filing
06 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Sale $468,470 -61,040 -18% $7.67* 280,224 05 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 6, 2022.
F2 Represents the weighted average sale price of the shares sold from $7.37 to $7.87 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.